Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to today's conference call from Omeros Corporation. At this time, all participants are in a listen-only mode.

Related Keywords

Indiana ,United States ,American ,Cathy Melfi ,Serge Belanger ,Greg Demopulos ,Nadia Dac ,Mike Jacobson ,Steven Whitaker ,Gregory Demopulos ,Steve Brozak ,Catherine Melfi ,Stephen Brozak ,Peter Cancelmo ,Andreas Grauer ,Steve Whitaker ,Olivia Brayer ,Michael Jacobsen ,Sarah Cannon Research Institute ,European Hematology Association ,International Blood ,Omeros Corp ,Emory University ,National Institute On Drug Abuse ,American Society For Transplantation ,Investigators Of Memorial Sloan Kettering Cancer Center ,Marrow Transplant Research ,Jefferies Research Group ,Office Of New Drugs ,European Medicines Agency ,Novartis ,American Society Of Hematology ,University Of Arkansas ,Omeros Corporation ,Cantor Fitzgerald ,Call Transcript April ,General Counsel ,Risk Factor ,Omero Chairman ,Chief Accounting Officer ,Chief Commercial Officer ,Chief Medical Officer ,Chief Regulatory Officer ,Clinical Vice President ,Rayner Surgical ,Memorial Sloan Kettering Cancer Center ,American Society ,Cellular Therapy ,Indiana Blood ,American Journal ,Kidney Diseases ,Annual Congress ,National Institute ,Drug Abuse ,Taxed States ,Obese Countries ,New Drugs ,